UK biotech companies raised more than £1billion ($1.3 billion) in equity finance between June and August 2020, the highest quarter for investments in the sector on record, according to new data published today by the BioIndustry Association (BIA) and Clarivate.
With £1.9 billion raised to date this year, 2020 is on target to be the best year ever recorded for this rapidly expanding sector, says the trade group.
The new report shows:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze